SPOTLIGHT -
EP. 1: Introduction: Monoclonal Antibodies in Multiple Myeloma
EP. 2: Elotuzumab and Daratumumab in Multiple Myeloma
EP. 3: Treatment Goals in Newly Diagnosed Multiple Myeloma
EP. 4: Frontline Treatments for Multiple Myeloma
EP. 5: Evolving Role of Stem Cell Transplant in Multiple Myeloma
EP. 6: Defining High-Risk Multiple Myeloma
EP. 7: Maintenance Therapy in Multiple Myeloma
EP. 8: Continuous Therapy in Multiple Myeloma
EP. 9: Treating Relapsed and Refractory Multiple Myeloma
EP. 10: HDAC Inhibitors in Multiple Myeloma
EP. 11: Triplet Therapy in Multiple Myeloma
EP. 12: Second-Generation Agents in Relapsed Multiple Myeloma
EP. 13: ENDEAVOR and CHAMPION Trials in Multiple Myeloma
EP. 14: Diagnostic and Response Criteria in Multiple Myeloma
EP. 15: Emerging Concepts in Multiple Myeloma
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
